Healthcare Global Enterprises moves up on launching new cancer hospital in North Bengaluru
Healthcare Global Enterprises is currently trading at Rs. 650.90, up by 4.20 points or 0.65% from its previous closing of Rs. 646.70 on the BSE.
The scrip opened at Rs. 648.95 and has touched a high and low of Rs. 654.90 and Rs. 632.55 respectively. So far 3057 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 799.47 on 29-Oct-2025 and a 52 week low of Rs. 511.91 on 20-Jun-2025.
Last one week high and low of the scrip stood at Rs. 661.95 and Rs. 538.20 respectively. The current market cap of the company is Rs. 9701.66 crore.
The promoters holding in the company stood at 64.21%, while Institutions and Non-Institutions held 21.66% and 14.13% respectively.
Healthcare Global Enterprises has launched new comprehensive cancer hospital in Hebbal with up to 132 beds, strengthening access to advanced oncology care in North Bengaluru (HCG Cancer Hospital, Hebbal). The new facility marks a major advancement in the region’s oncology landscape, bringing together clinical excellence, compassionate care and advanced technology to make world-class cancer treatment more accessible to people across Karnataka.
Marking a significant milestone in precision oncology, the new facility introduces Karnataka’s first Elekta Unity MR-Linac, one of the world’s most advanced precision radiation therapy platforms. The technology combines high-quality MRI imaging with a linear accelerator to enable highly precise, adaptive cancer treatment. Designed as a full-spectrum oncology centre, the hospital brings together diagnosis, treatment, recovery support, and patient-centric care under one roof, making world-class cancer care more accessible to patients across North Bengaluru.
